| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963076 | Vaccine | 2016 | 5 Pages |
Abstract
The risk of developing VTE among 9- to 26-year-olds was not elevated following HPV4 exposure. Sample size limited our ability to rigorously evaluate potential effect modifiers, such as gender, through stratified analysis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Allison L. Naleway, Brad Crane, Ning Smith, Matthew F. Daley, James Donahue, Julianne Gee, Sharon K. Greene, Theresa Harrington, Lisa A. Jackson, Nicola P. Klein, Hung Fu Tseng, Claudia Vellozzi, Eric S. Weintraub,